Ind-Swift Laboratories Q3FY22 consolidated net profit drops QoQ to Rs. 16.02 crores

Ind-Swift Laboratories Limited has reported Consolidated financial results for the period ended December 31, 2021.

Financial Results (Q3 FY2022) - QoQ Comparison

The company has reported total income of Rs. 255.0467 crores during the period ended December 31, 2021 as compared to Rs. 242.7898 crores during the period ended September 30, 2021.

The company has posted net profit / (loss) of Rs. 16.0295 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs. 24.4705 crores for the period ended September 30, 2021.

The company has reported EPS of Rs. 2.71 for the period ended December 31, 2021 as compared to Rs. 4.14 for the period ended September 30, 2021.

Financials	Q3 FY2022	Q2 FY2022	% Change
Total Income	₹ 255.0467 crs	₹242.7898 crs	5.05%
Net Profit	₹16.0295 crs	₹24.4705 crs	-34.49%
EPS	₹2.71	₹4.14	-34.54%

Financial Results (Q3 FY2022) - YoY Comparison

The company has reported total income of Rs. 255.0467 crores during the period ended December 31, 2021 as compared to Rs.235.1011 crores during the period ended December 31, 2020.

The company has posted net profit / (loss) of Rs.16.0295 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs.11.5484 crores for the period ended December 31, 2020.

The company has reported EPS of Rs.2.71 for the period ended December 31, 2021 as compared to Rs.1.95 for the period ended December 31, 2020.

Financials	Q3 FY2022	Q3 FY2021	% Change
Total Income	₹ 255.0467 crs	₹235.1011 crs	8.48%
Net Profit	₹16.0295 crs	₹11.5484 crs	38.80%
EPS	₹2.71	₹1.95	38.97%

Financial Results (9 Months Ended FY2022) - YoY Comparison

The company has reported total income of Rs.753.5888 crores during the 9 Months period ended December 31, 2021 as compared to Rs.684.9305 crores during the 9 Months period ended December 31, 2020.

The company has posted net profit / (loss) of Rs.59.3042 crores for the 9 Months period ended December 31, 2021 as against net profit / (loss) of Rs.26.0425 crores for the 9 Months period ended December 31, 2020.

The company has reported EPS of Rs.10.04 for the 9 Months period ended December 31, 2021 as compared to Rs.4.41 for the 9 Months period ended December 31, 2020.

Financials	9 Months Ended FY2022	9 Months Ended FY2021	% Change
Total Income	₹753.5888 crs	₹684.9305 crs	10.02%
Net Profit	₹59.3042 crs	₹26.0425 crs	127.72%
EPS	₹10.04	₹4.41	127.66%

Shares of Ind-Swift Laboratories Limited was last trading in BSE at Rs. 86.95 as compared to the previous close of Rs. 88.00. The total number of shares traded during the day was 24569 in over 746 trades.

The stock hit an intraday high of Rs. 89.65 and intraday low of 83.70. The net turnover during the day was Rs. 2113620.00.

Source : Equity Bulls

Keywords

IndSwiftLaboratories Q3FY22 9MFY22 ResultUpdate